Murray Mark J. 4
4 · Arbutus Biopharma Corp · Filed Nov 30, 2018
Insider Transaction Report
Form 4
Murray Mark J.
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Shares
2018-11-28$1.35/sh+25,000$33,750→ 341,396 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-11-28−25,000→ 0 totalExercise: $1.35Exp: 2018-12-08→ Common Shares (25,000 underlying)
Footnotes (2)
- [F1]Converted from an exercise price of C$1.80 based on a conversion rate of C$1.33:$1.00 as of November 28, 2018.
- [F2]The option vested 1/4 on December 8, 2008, with the remaining portion vesting in equal annual installments beginning on December 8, 2009.